Several other brokerages have also commented on GNS. Kepler Capital Markets assumed coverage on shares of Genus plc in a research report on Tuesday, November 7th. They set a hold rating and a GBX 2,353 ($30.95) target price on the stock. Liberum Capital restated a hold rating and set a GBX 2,100 ($27.62) target price on shares of Genus plc in a research report on Monday, October 9th. N+1 Singer upgraded shares of Genus plc to a buy rating and boosted their target price for the stock from GBX 1,844 ($24.25) to GBX 2,485 ($32.68) in a research report on Monday, October 30th. Finally, Numis Securities Ltd restated a hold rating and set a GBX 1,815 ($23.87) target price on shares of Genus plc in a research report on Thursday, September 7th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of GBX 2,270.60 ($29.86).
Genus plc (LON:GNS) opened at GBX 2,192 ($28.83) on Wednesday. Genus plc has a 1 year low of GBX 1,652 ($21.73) and a 1 year high of GBX 2,500 ($32.88).
About Genus plc
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with MarketBeat.com's FREE daily email newsletter.